CareLit CareLitFachliteratur für Gesundheitsberufe
CareLit · DOI-Nachweis · Pneumologie

Long-term safety and durability of mepolizumab in life-threatening/seriously debilitating severe eosinophilic asthma (SEA): COSMEX

FC Albers, S Khurana, E Bradford, M Gilson, R Price, G Brusselle, E Bel, JM FitzGerald, M Masoli, S Korn, M Humbert · Pneumologie · Ausgabe S 01 S 01/2020

DOI 10.1055/s-0039-3403113

Bibliografische Angaben

Nachweis in CareLit

Autor:innenFC Albers, S Khurana, E Bradford, M Gilson, R Price, G Brusselle, E Bel, JM FitzGerald, M Masoli, S Korn, M Humbert
ZeitschriftPneumologie
AusgabeS 01 S 01/2020
Jahrgang / SeitenJg. 74

Kernaussage aus der Literatur

Abstract-Vorschau

Long-term safety and durability of mepolizumab in life-threatening/seriously debilitating severe eosinophilic asthma (SEA): COSMEX

Zitieren

Zitierempfehlung

FC Albers, S Khurana, E Bradford, M Gilson, R Price, G Brusselle, E Bel, JM FitzGerald, M Masoli, S Korn, M Humbert (2020) Long-term safety and durability of mepolizumab in life-threatening/seriously debilitating severe eosinophilic asthma (SEA): COSMEX. Pneumologie, 74 (S 01 S 01). https://doi.org/10.1055/s-0039-3403113

Mit CareLit weiterarbeiten

Volltext, Abstract und ähnliche Literatur